Stock TFX TELEFLEX INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Teleflex Incorporated

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:01 2024-05-09 pm EDT 		5-day change 1st Jan Change
204.7 USD +2.12% Intraday chart for Teleflex Incorporated +3.00% -17.90%
May. 09 Teleflex Incorporated Expands Intraosseous Vascular Access Portfolio with New Arrow? EZ-IO? Intraosseous Access Procedure Tray CI
May. 06 Teleflex Maintains Dividend at $0.34 per Share; Payable on June 14 to Shareholders of Record on May 15 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 17,428 19,165 15,388 11,709 11,717 9,442 - -
Enterprise Value (EV) 1 19,035 21,268 16,793 13,129 13,309 10,506 9,948 9,261
P/E ratio 38.4 x 58 x 32.1 x 32.5 x 33.1 x 26.4 x 18.2 x 16.1 x
Yield 0.36% 0.33% 0.41% 0.54% 0.55% 0.67% 0.67% 0.67%
Capitalization / Revenue 6.71 x 7.55 x 5.48 x 4.2 x 3.94 x 3.06 x 2.9 x 2.74 x
EV / Revenue 7.33 x 8.38 x 5.98 x 4.7 x 4.47 x 3.4 x 3.05 x 2.69 x
EV / EBITDA 25.9 x 30.3 x 19.6 x 16 x 15.6 x 11.8 x 10.3 x 9.01 x
EV / FCF 56.9 x 61.4 x 28.9 x 49.8 x 31.7 x 17.1 x 15.7 x 12.8 x
FCF Yield 1.76% 1.63% 3.46% 2.01% 3.16% 5.84% 6.36% 7.83%
Price to Book 5.84 x 5.76 x 4.19 x 2.91 x 2.66 x 1.99 x 1.83 x 1.66 x
Nbr of stocks (in thousands) 46,296 46,567 46,845 46,906 46,993 47,103 - -
Reference price 2 376.4 411.6 328.5 249.6 249.3 204.7 204.7 204.7
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,595 2,537 2,810 2,791 2,974 3,089 3,260 3,441
EBITDA 1 734.2 701.1 858.4 820.1 855.5 887.2 961.4 1,027
EBIT 1 670.1 632.6 786.7 753.6 788.2 821.8 890 966.8
Operating Margin 25.82% 24.93% 28% 27% 26.5% 26.61% 27.3% 28.09%
Earnings before Tax (EBT) 1 - 357.7 559.5 445.9 434 315.8 658 743.7
Net income 1 461.5 335.3 485.4 363.1 356.3 408.8 542.7 615.3
Net margin 17.78% 13.22% 17.28% 13.01% 11.98% 13.24% 16.65% 17.88%
EPS 2 9.800 7.090 10.23 7.680 7.530 7.757 11.27 12.74
Free Cash Flow 1 334.4 346.4 580.5 263.6 420.2 614 632.8 725.1
FCF margin 12.88% 13.66% 20.66% 9.45% 14.13% 19.88% 19.41% 21.07%
FCF Conversion (EBITDA) 45.55% 49.41% 67.63% 32.15% 49.12% 69.21% 65.82% 70.57%
FCF Conversion (Net income) 72.46% 103.32% 119.6% 72.59% 117.94% 150.19% 116.61% 117.85%
Dividend per Share 2 1.360 1.360 1.360 1.360 1.360 1.365 1.375 1.380
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 761.9 641.7 704.5 686.8 758 710.9 743.3 746.4 773.9 737.8 763 773 814.5 775.7 804.5
EBITDA 1 228.2 182.2 209.9 200 228.9 201.7 216.1 218.8 219.1 212.2 218.1 221 240.4 229.4 236.6
EBIT 1 210.3 164.9 193.7 184.4 211.5 183.4 197.7 202.8 203.5 196.3 200.2 202.8 221.9 208 217
Operating Margin 27.6% 25.7% 27.5% 26.86% 27.9% 25.8% 26.6% 27.17% 26.3% 26.6% 26.24% 26.24% 27.25% 26.82% 26.98%
Earnings before Tax (EBT) 1 - 93.34 - 119.2 109.4 97.48 127 - 59.97 -25.81 181.6 184.7 203 190.5 202
Net income 1 128.1 77.14 105.5 101.9 78.59 76.75 111.3 137.1 31.1 15.29 123.8 130 141.1 135.3 143.4
Net margin 16.81% 12.02% 14.98% 14.84% 10.37% 10.8% 14.98% 18.37% 4.02% 2.07% 16.23% 16.81% 17.32% 17.44% 17.82%
EPS 2 2.700 1.630 2.230 2.160 1.660 1.620 2.350 2.900 0.6600 0.3200 2.494 2.584 2.850 2.833 3.025
Dividend per Share 2 0.3400 - 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400 0.3400
Announcement Date 2/24/22 4/28/22 7/28/22 10/27/22 2/23/23 5/4/23 8/3/23 11/2/23 2/22/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,608 2,103 1,405 1,419 1,592 1,065 507 -
Net Cash position 1 - - - - - - - 180
Leverage (Debt/EBITDA) 2.19 x 2.999 x 1.637 x 1.731 x 1.861 x 1.2 x 0.5271 x -
Free Cash Flow 1 334 346 581 264 420 614 633 725
ROE (net income / shareholders' equity) 19% 16% 17.8% 15.9% 8.42% 11.2% 11.7% 12.4%
ROA (Net income/ Total Assets) 8.34% 7.5% 9.02% 8.95% 4.93% 3.5% 5.2% 5.9%
Assets 1 5,532 4,471 5,384 4,056 7,230 11,681 10,436 10,428
Book Value Per Share 2 64.50 71.50 78.30 85.70 93.90 103.0 112.0 124.0
Cash Flow per Share 2 - 9.240 13.80 7.250 10.80 18.00 17.60 17.90
Capex 1 103 90.7 71.6 79.2 91.4 101 111 122
Capex / Sales 3.96% 3.57% 2.55% 2.84% 3.07% 3.26% 3.39% 3.54%
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Teleflex Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
204.7 USD
Average target price
245.2 USD
Spread / Average Target
+19.80%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
TELEFLEX INCORPORATED Stock Teleflex Incorporated
-17.90% 9.44B
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.91% 183B
MEDTRONIC PLC Stock Medtronic plc
+0.46% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.62% 67.51B
DEXCOM, INC. Stock DexCom, Inc.
+3.26% 50.67B
CENCORA, INC. Stock Cencora, Inc.
+9.11% 44.7B
HOYA CORPORATION Stock Hoya Corporation
+2.55% 40.95B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+6.39% 26.8B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.83% 26.71B
TERUMO CORPORATION Stock Terumo Corporation
+14.04% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. TFX Stock
  4. Financials Teleflex Incorporated
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW